Alembic Pharma slips as US FDA issues Form 483 to Panelav facility 0 18.10.2022 09:20 Business Standard Alembic Pharmaceuticals declined 1.26% to Rs 562.35 after the firm received a Form 483 with four procedural observations for an inspection conducted by USFDA at its Panelav formulation facility. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа Другие проекты от SMI24.net Музыкальные новости Агрегатор новостей 24СМИ
